3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
3
Terminated
2
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
372
Precursor Cell Lymphoblastic Leukemia-Lymphoma
292
Leukemia
218
Hematologic Neoplasms
160
Leukemia, Lymphocytic, Chronic, B-Cell
129
Lymphoma
107
Myelodysplastic Syndromes
90
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Lymphoma, Non-Hodgkin
66
Recurrence
63
Lymphoma, Large B-Cell, Diffuse
50
Lymphoma, Follicular
47
Lymphoma, Mantle-Cell
44
Multiple Myeloma
42
Burkitt Lymphoma
41
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
39
Leukemia, B-Cell
39
Neoplasms
38
Leukemia, Myeloid, Chronic-Phase
37
Lymphoma, B-Cell
36
Lymphoma, B-Cell, Marginal Zone
31
Hodgkin Disease
29
Lymphoma, Large-Cell, Immunoblastic
26
Leukemia, Promyelocytic, Acute
23
Leukemia, Myelomonocytic, Chronic
21
Neoplasms, Plasma Cell
19
Myeloproliferative Disorders
19
Congenital Abnormalities
19
Leukemia, Myelomonocytic, Acute
18
Leukemia, Myeloid
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Primary Immunodeficiency Diseases
×
Other hematologic neoplasm
×
Clear all
NCT03836690
2019-10-25
ToTem
University College, London
Phase 1
Unknown
18 enrolled